Johnson & Johnson (NYSE: JNJ) announced the appointment of Ryan Koors as Vice President, Investor Relations, effective May 7, 2026. Koors will report to Executive Vice President and Chief Financial Officer Joseph J. Wolk.

Koors succeeds Darren Snellgrove, who is leaving the company to become chief financial officer of Halozyme.

Koors brings more than 20 years of experience within Johnson & Johnson's finance organization. He most recently served as Chief Financial Officer and Vice President of Finance for Innovative Medicine Global Research & Development. His previous roles included Vice President of Finance for MedTech Surgery and Vice President of Finance for Johnson & Johnson MedTech Supply Chain.

Koors joined Johnson & Johnson in 2002. He holds a bachelor's degree in finance from Wright State University and an MBA from Xavier University.

"Ryan's appointment underscores the deep bench of financial talent within Johnson & Johnson and our commitment to developing leaders across the Company," Wolk said in a statement. "With his deep knowledge of our business and proven financial expertise, Ryan is exceptionally well positioned to lead our Investor Relations function."

The appointment represents an internal promotion as Johnson & Johnson fills the investor relations leadership position from its existing finance talent pool.